Novo Nordisk plunged 8%; its new weight-loss pill was "copied" as soon as it hit the market, with telemedicine company Hims launching a $49 generic version.
Just as Novo Nordisk’s newly launched weight loss pill was trying to find its footing, it has been hit by an unexpected market challenge.
On Thursday, February 5th, Novo Nordisk’s stock plunged sharply, after telehealth company Hims & Hers Health introduced a generic version of Novo Nordisk’s